Skip to content

Clinical trials

Sarcoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20083
20101
20112
20131
20153
20162
20172
20181
20194
20204
20211
20231
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting8
Terminated3
Unknown status3
Active, not recruiting2
Not yet recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University7
Eli Lilly and Company3
Asan Medical Center2
Bayer2
Pfizer2
Samsung Medical Center2
Turning Point Therapeutics, Inc.2
Daiichi Sankyo1
Eisai Inc.1
Elevation Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma31
Breast Neoplasms6
Colorectal Neoplasms6
Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Head and Neck Neoplasms4
Melanoma4
Neoplasm Metastasis4
Ovarian Neoplasms4
Lung Neoplasms3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.